Position history for TD ASSET MANAGEMENT INC's holdings in MOONLAKE IMMUNOTHERAPEUTICS
TD ASSET MANAGEMENT INC holds 142,706 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), worth $2.7M as of 2026-Q1. The position was increased (+12.6% shares). MLTX represents 0.0% of TD ASSET MANAGEMENT INC's portfolio.
Current Value
$2.7M
Current Shares
142,706
Total Value Change
-$6.5M
Total Shares Change
-66,528
Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/
Increased |
| 142,706 |
+12.6% |
| $2.7M |
| 0.0% |
| $17.69 |
30 |
| 2025-Q4 | Increased | 126,744 | +18.9% | $1.7M | 0.0% | $13.21 | 30 |
| 2025-Q3 | Decreased | 106,610 | -42.7% | $764,394 | 0.0% | $6.24 | 0 |
| 2025-Q2 | Decreased | 186,152 | -14.2% | $8.8M | 0.0% | $47.52 | 0 |
| 2025-Q1 | Decreased | 216,904 | -17.1% | $8.5M | 0.0% | $39.86 | 0 |
| 2024-Q4 | Increased | 261,634 | +21.2% | $14.2M | 0.0% | $53.02 | 34 |
| 2024-Q3 | Increased | 215,834 | +3.1% | $10.7M | 0.0% | $49.40 | 29 |
| 2024-Q2 | Increased | 209,234 | +2.5% | $9.2M | 0.0% | $43.97 | 28 |